Reversible inhibition of albumin production by rat hepatocytes maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines-Reference-Cited by-同舟云学术

Reversible inhibition of albumin production by rat hepatocytes maintained on a laminin-rich gel (Engelbreth-Holm-Swarm) in response to secretory products of Kupffer cells and cytokines

Published:1992-09 Issue:3 Volume:16 Page:733-741
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kowalski-Saunders Peter W. J.,Winwood Paul J.,Arthur Michael J. P.,Wright Ralph

Publisher

Wiley

Subject

Hepatology

Reference41 articles.

1. Oxygen-derived free radicals promote hepatic injury in the rat

2. , , , . Population kinetics of rat liver macrophages after intravenous administration of liposome-encapsulated MDP. In: , , eds. Cells of the hepatic sinusoid. Vol 2. Netherlands: Kupffer Cell Foundation, 1989; 400–405.

3. , , , . Glucan stimulates the in vitro proliferation of murine Kupffer cells. In: , eds. Cells of the hepatic sinusoid. Vol 2. Netherlands: Kupffer Cell Foundation, 1989: 390–393.

4. What is Kupffer cell activation? In: , eds. Cells of the hepatic sinusoid. Vol 1. Netherlands: Kupffer Cell Foundation, 1986; 269–275.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer;Cancer Research and Treatment;2023-07-15

2. Correlation between the Immune Checkpoint Inhibitors Prognostic Index and Outcomes in Nonsmall Cell Lung Cancer: A Multicentre Analysis;Journal of Oncology;2022-08-26

3. Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer;Annals of Coloproctology;2022-04-30

4. Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma;Biomedicines;2022-01-17

5. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group;eJHaem;2020-07